UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017888
Receipt number R000020680
Scientific Title Influence of repetitive transcranial magnetic stimulation of cerebral cortex on eye movement of Parkinson's disease and syndrome
Date of disclosure of the study information 2015/06/12
Last modified on 2019/06/17 09:56:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Influence of repetitive transcranial magnetic stimulation of cerebral cortex on eye movement of Parkinson's disease and syndrome

Acronym

Influence of rTMS of brain on eye movement of Parkinson's syndrome

Scientific Title

Influence of repetitive transcranial magnetic stimulation of cerebral cortex on eye movement of Parkinson's disease and syndrome

Scientific Title:Acronym

Influence of rTMS of brain on eye movement of Parkinson's syndrome

Region

Japan


Condition

Condition

Parkinson's disease and syndrome

Classification by specialty

Neurology Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In Parkinson's disease and syndrome, motor symptoms are improved by rTMS of cerebral cortex. We will analyze the improvements of eye movement of them.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Evaluation of improvement of eye movements

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

repetitive transcranial magnetic stimulation of bilateral motor cortex

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Parkinson's disease, Parkinson syndrome

Key exclusion criteria

1 cannot sit for an hour
2 cognitive disorder MMSE under 24 points
3 hallucination
4 astigmatism
5 narrowing of visual field
6 intake of drug which may induce Parkinsonism within 6 months
7 combination with other neuro-mascular diseases
8 past history of cerebro-vascular disease and infectious diseases of CNS
9 cerebral infarction in basal ganglia and brain stem with MRI
10 metal in the patient's head without mouse
11 patients receiving pace maker and drug delivery pump
12 severe heart diseases
13 patients receiving DBS and SCS
14 cerebral infarction with stem arteries, brain tumors, traumatic brain injuries, epilepsy
15 pregnant and women who plan to be pregnant
16 patients who the doctors consider inappropriate

Target sample size

5


Research contact person

Name of lead principal investigator

1st name Youichi
Middle name
Last name Saitoh

Organization

Osaka University Graduate School of Medicine

Division name

Department of Neuromodulation and Neurosurgery

Zip code

5650871

Address

Yamadaoka 2-2, Suita, Osaka

TEL

06-6210-8435

Email

saitoh@nsurg.med.osaka-u.ac.jp


Public contact

Name of contact person

1st name Tomoo
Middle name
Last name Mano

Organization

Osaka University Graduate School of Medicine

Division name

Department of Neuromodulation and Neurosurgery

Zip code

5650871

Address

Yamadaoka 2-2, Suita, Osaka

TEL

06-6210-8435

Homepage URL


Email

mano@neuromod.med.osaka-u.ac.jp


Sponsor or person

Institute

Osaka University ospital

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka University Ethics Commitee

Address

2-2 Yamadaoka, Suita, Osaka, Japan , Osaka

Tel

06-6879-8290

Email

shiken@hp-crc.med.osaka-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪大学医学部附属病院


Other administrative information

Date of disclosure of the study information

2015 Year 06 Month 12 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 12 Month 10 Day

Date of IRB

2014 Year 12 Month 10 Day

Anticipated trial start date

2015 Year 06 Month 12 Day

Last follow-up date

2020 Year 12 Month 31 Day

Date of closure to data entry

2020 Year 12 Month 31 Day

Date trial data considered complete

2020 Year 12 Month 31 Day

Date analysis concluded

2020 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2015 Year 06 Month 12 Day

Last modified on

2019 Year 06 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020680


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name